Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma publication / By Serafim Nenarokov
Mutagenic impact and evolutionary influence of chemo-radiotherapy in hematologic malignancies publication / By Serafim Nenarokov
Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group publication / By Serafim Nenarokov
European Myeloma Network Group review and consensus statement on primary plasma cell leukemia publication / By Serafim Nenarokov
Level of Clonal Plasma Cells in Hematopoietic Cell Autografts Reflects the Pre-Transplant Bone Marrow Minimal Residual Disease in Multiple Myeloma Patients publication / By Serafim Nenarokov
Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies publication / By David Žihala
Liquid biopsy of peripheral blood using mass spectrometry detects primary extramedullary disease in multiple myeloma patients publication / By David Žihala
K128 ubiquitination constrains RAS activity by expanding its binding interface with GAP proteins publication / By David Žihala
Real-World Evidence on Prognostic Value of MRD in Multiple Myeloma Using Flow Cytometry publication / By David Žihala
Deubiquitinase BAP1 is crucial for surface expression of T cell receptor (TCR) complex, T cell-B cell conjugate formation, and T cell activation publication / By David Žihala